OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
September 09, 2010
The Society for Chemical Manufacturers and Affiliates (SOCMA) issued recommendations relating to disclosure of confidential business information (CBI) in response to Environmental Protection Agency's (EPA) decision to limit CBI claims on chemical identity under the Toxic Substances Control Act (TSCA).
September 02, 2010
Pharmaceutical Technology gains insight into approaches for producing aromatic amines.
The President's Council on Advisors on Science and Technology (PCAST), a group administered by the federal Office of Science and Technology Policy (OSTP), issued recommendations to improve the country's ability to accelerate vaccine production and delivery in the event of a pandemic flu outbreak.
September 01, 2010
An upcoming summit will assess the progress and gaps in realizing the UN Millennium Development Goals, including outcomes from global health initiatives.
Bristol-Myers Squibb's fit-for-purpose mode for clinical-trial materials for early-stage development seeks to achieve a better way in resource allocation. This article is part of a special issue on API Development, Formulation, Synthesis and Manufacturing.
Procurement, sourcing, and partnerships with external suppliers take on greater importance as the pharmaceutical supply chain becomes increasingly more complex and global.